Search clinical trials for: Casodex
Total 361 results
-
University of Colorado, DenverUnited States Department of DefenseActive, not recruitingBreast CancerUnited States
-
Stanford UniversityAstraZenecaCompletedProstatic Neoplasms | Prostate CancerUnited States
-
AstraZenecaCompleted
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZenecaCompletedSystemic Lupus ErythematosusUnited States
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.Terminated
-
University of FloridaGlaxoSmithKline; Food and Drug Administration (FDA)CompletedHypersensitivityUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
BeiGeneRecruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid Tumor | Endometrial Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States, Australia
-
University of California, IrvineEli Lilly and CompanyTerminatedBreast Neoplasm | Hormone Receptor Positive Breast CarcinomaUnited States
-
Organon and CoCompleted
-
University of Wisconsin, MadisonUnited States Department of Defense; Prostate Cancer FoundationCompletedProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States
-
Washington University School of MedicineCompletedChronic Rhinosinusitis (Diagnosis) | Allergic Rhinosinusitis | Chronic Eosinophilic RhinosinusitisUnited States
-
University of Wisconsin, MadisonPfizerTerminatedProstate CancerUnited States
-
Phoenix Molecular DesignsActive, not recruitingMetastatic Breast CancerUnited States
-
Eagle Pharmaceuticals, Inc.CompletedPharmacokineticsUnited States
-
Intersect ENTCompletedChronic Sinusitis | Nasal PolypsUnited States
-
Tigris PharmaceuticalsTerminated
-
Carrick Therapeutics LimitedCompletedAdvanced Solid MalignanciesUnited States, United Kingdom
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
Organon and CoCompleted
-
University of Colorado, DenverUnited States Department of DefenseCompleted
-
GOG FoundationNovartisRecruitingEndometroid Endometrial CancerUnited States
-
Hoffmann-La RocheTerminatedBreast CancerItaly, United States, Korea, Republic of, Canada, Czechia, Spain, Australia, Bulgaria, China, Finland, France, Greece, Poland, Portugal, Taiwan, Thailand, Turkey, Colombia, Bosnia and Herzegovina, Mexico, Peru, Romania, Russian Federation and more
-
SandozCompletedRhinitis, Allergic, SeasonalUnited States
-
University of Kansas Medical CenterCompletedProstate CancerUnited States
-
Translational Oncology Research InternationalUniversity of California, Los Angeles; AstraZeneca; Genentech, Inc.Terminated
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Treadwell Therapeutics, IncRecruitingBreast Cancer | Advanced Solid TumorUnited States
-
Medical University of South CarolinaCompleted
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Borstkanker Onderzoek GroepNovartis Pharma B.V.; BOOG Study CenterRecruitingNeoplasm, Breast | Congenital, Familial and Genetic DisordersNetherlands
-
AstraZenecaCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
Fudan UniversityActive, not recruiting
-
SanofiRegeneron PharmaceuticalsCompletedNasal PolypsSpain, Belgium, United States, Sweden
-
SunovionCompletedPerennial Allergic RhinitisUnited States
-
Mara ChambersNovartisCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedProstate CancerUnited States
-
Pamela MunsterPfizer; Xynomic Pharmaceuticals, Inc.WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
State University of New York at BuffaloNot yet recruiting
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States